Parkinsonism:
Indications for: AKINETON
Adjunct in the therapy of all forms of parkinsonism (eg, idiopathic, postencephalitic, arteriosclerotic). To control extrapyramidal disorders secondary to neuroleptic drug therapy (eg, phenothiazines).
Adult Dosage:
Parkinson's disease: 2mg three or four times daily. Individualize and titrate upward to max 16mg/24 hours. Extrapyramidal disorders: 2mg one to three times daily.
Children Dosage:
Not recommended.
AKINETON Contraindications:
Narrow angle glaucoma. Bowel obstruction. Megacolon.
AKINETON Warnings/Precautions:
Glaucoma. Prostatism. Epilepsy. Arrhythmia. Pregnancy (Cat.C). Nursing mothers.
AKINETON Classification:
Anticholinergic.
AKINETON Interactions:
Avoid concomitant alcohol. Potentiated anticholinergic effects with drugs that have secondary anticholinergic actions (eg, narcotics analgesics, phenothiazines, tricyclic antidepressants, antiarrhythmics, antihistamines).
Adverse Reactions:
Anticholinergic effects (eg, dry mouth, blurred vision, drowsiness, euphoria, disorientation, urinary retention, postural hypotension, constipation, agitation, disturbed behavior); rare: generalized choreic movements, reduction in REM sleep.
How Supplied:
Tabs—100
